Back to Search
MICHAEL GLANTZ, M.D.
M.D.
Neurological Surgery Physician
NPI: 1568457695IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
MD439695(PA)
CMS Specialties
PrimaryNEUROLOGY
Education
WARREN ALPERT MEDICAL SCHOOL OF BROWN UNIVERSITY
Class of 1984
Research & Publications (20)
Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay.
PMID 19660679·Semin Oncol·2009
3-trial
The science of prevention: novel strategies for and new insights into central nervous system prophylaxis in patients with cancer.
PMID 19660678·Semin Oncol·2009
8-other
Gender disparity in the rate of partner abandonment in patients with serious medical illness.
PMID 19645027·Cancer·2009
4-observational
Is Central Asia the eastern outpost of the Neandertal range? A reassessment of the Teshik-Tash child.
PMID 18711730·Am J Phys Anthropol·2009
7-preclinical
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of Neurology.
PMID 10822423·Neurology·2000
6-review
Statistical and trial design considerations in central nervous system prophylaxis studies.
PMID 19660685·Semin Oncol·2009
6-review
Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
PMID 19139302·Arch Neurol·2009
8-other
New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer.
PMID 18936791·Nat Clin Pract Oncol·2009
6-review
Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey.
PMID 19549055·Addiction·2009
8-other
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.
PMID 18820836·J Neurooncol·2009
3-trial
Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
PMID 19660681·Semin Oncol·2009
2-rct
Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.
PMID 19046473·Psychol Med·2009
8-other
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
PMID 19660682·Semin Oncol·2009
6-review
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
PMID 18977094·Int J Radiat Oncol Biol Phys·2009
3-trial
Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication.
PMID 18466664·Psychol Med·2009
8-other
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
PMID 18981882·Neurosurgery·2008
8-other
Improving targets for the prevention of drug use disorders: sociodemographic predictors of transitions across drug use stages in the national comorbidity survey replication.
PMID 18926848·Prev Med·2008
8-other
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
PMID 18981465·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 UNIVERSITY DR
HERSHEY, PA 17033 - Phone
- (800) 243-1455
Quick Facts
- NPI
- 1568457695
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile